相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
L. Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis
Troy Noordenbos et al.
ARTHRITIS AND RHEUMATISM (2012)
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study
P. Rich et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
IL-17 receptor and its functional significance in psoriatic arthritis
Siba P. Raychaudhuri et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
Andrea Chiricozzi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
Wolfgang Hueber et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
Alice Gottlieb et al.
LANCET (2009)
β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin
Patrick A. M. Jansen et al.
PLOS ONE (2009)
Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides
Camilla Jandus et al.
ARTHRITIS AND RHEUMATISM (2008)
Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs
F. Cantini et al.
RHEUMATOLOGY (2008)
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
Lisa C. Zaba et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis
A Kavanaugh et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
PJ Mease et al.
ARTHRITIS AND RHEUMATISM (2005)
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
CE Antoni et al.
ARTHRITIS AND RHEUMATISM (2005)
Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17
MA Stark et al.
IMMUNITY (2005)
Etanercept treatment of psoriatic arthritis - Safety, efficacy, and effect on disease progression
PJ Mease et al.
ARTHRITIS AND RHEUMATISM (2004)
Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Poriasis Associations - Data from the Nordic Quality of Life Study
H Zachariae et al.
ACTA DERMATO-VENEREOLOGICA (2002)
分享论文
